MCID: CHL067
MIFTS: 58

Cholecystitis

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Cholecystitis

MalaCards integrated aliases for Cholecystitis:

Name: Cholecystitis 12 72 49 28 51 41 14 69
Chronic Cholecystitis 12 51 69
Acute Cholecystitis 12 51 69
Acute and Chronic Cholecystitis 12 69
Acalculous Cholecystitis 49 69
Calculus of Gallbladder with Cholecystitis 69
Acute Cholecystitis Unspecified 12
Acute on Chronic Cholecystitis 12
Acute Cholecystitis Nos 12
Gallstone Cholecystitis 49

Classifications:



External Ids:

Disease Ontology 12 DOID:1949
ICD9CM 34 575.10
MeSH 41 D002764
NCIt 46 C34465
SNOMED-CT 64 197414008 76581006

Summaries for Cholecystitis

Disease Ontology : 12 A cholangitis that is characterized_by an inflammation that is located in the gallbladder.

MalaCards based summary : Cholecystitis, also known as chronic cholecystitis, is related to cholelithiasis and hepatitis a. An important gene associated with Cholecystitis is ABCB4 (ATP Binding Cassette Subfamily B Member 4), and among its related pathways/superpathways are Pathways in cancer and Defective GALNT12 causes colorectal cancer 1 (CRCS1). The drugs Amoxicillin and Ketamine have been mentioned in the context of this disorder. Affiliated tissues include the gallbladder, liver and b cells, and related phenotypes are cellular and cardiovascular system

Wikipedia : 72 Cholecystitis is inflammation of the gallbladder. Symptoms include right upper abdominal pain, nausea,... more...

Related Diseases for Cholecystitis

Diseases related to Cholecystitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 383)
# Related Disease Score Top Affiliating Genes
1 cholelithiasis 30.5 ABCB4 ALB CCK GPT
2 hepatitis a 30.4 ALB F2 GPT
3 cholangitis 30.3 ABCB4 ALB F2 GPT
4 hemorrhagic fever 30.3 ALB F2 GPT
5 obstructive jaundice 30.1 ALB F2 GPT
6 choledocholithiasis 30.0 ABCB4 ALB F2 GPT
7 hellp syndrome 29.8 F2 GPT HP
8 hepatitis e 29.7 ALB F2 GPT
9 biliary tract disease 29.6 ABCB4 ALB CCK F2
10 adenocarcinoma 29.6 CDH1 CDKN2A MUC1 TP53
11 cholestasis 29.6 ABCB4 F2 GPT
12 myeloma, multiple 29.4 ALB CDKN2A TP53
13 bilirubin metabolic disorder 29.3 ALB F2 GPT HP
14 papillary adenocarcinoma 29.1 CDH1 MUC1 MUC2
15 adenosquamous carcinoma 28.9 KRT18 MUC1 TP53
16 viral hepatitis 28.8 ALB F2 GPT KRT18
17 gallbladder cancer 28.8 ABCB4 CDH1 CDKN2A MUC1 MUC2 TP53
18 squamous cell carcinoma 28.6 CDH1 CDKN2A DAPK1 MUC1 TP53
19 cholangiocarcinoma 28.0 CDH1 KRT18 MUC1 MUC2 RASSF1
20 hepatocellular carcinoma 27.8 ALB CDH1 CDKN2A F2 KRT18 RASSF1
21 gastric cancer 27.1 CDH1 CDKN2A DAPK1 MUC1 MUC2 MUC6
22 bladder cancer 26.6 CDH1 CDKN2A DAPK1 KRT18 MUC1 MUC2
23 acalculous cholecystitis 12.4
24 emphysematous cholecystitis 12.4
25 xanthogranulomatous cholecystitis 12.2
26 gallbladder disease 1 11.8
27 mirizzi syndrome 11.2
28 bisphosphoglycerate mutase deficiency 10.9
29 duodenal atresia 10.9
30 dicrocoeliasis 10.9
31 opisthorchiasis 10.9
32 cerebral convexity meningioma 10.5 CDH1 TP53
33 hepatoportal sclerosis 10.5 F2 GPT
34 antipyrine metabolism 10.5 ALB F2
35 non-a-e hepatitis 10.5 ALB F2
36 paralytic ileus 10.5 ALB CCK
37 fournier gangrene 10.5 ALB F2
38 abdominal tuberculosis 10.5 ALB F2
39 papilledema 10.4 F2 TP53
40 ascending cholangitis 10.4 ALB CCK F2
41 kwashiorkor 10.4 ALB F2 GPT
42 hepatic tuberculosis 10.4 ALB F2 GPT
43 brain stem astrocytic neoplasm 10.4 CDKN2A TP53
44 hepatic coma 10.4 ALB F2 GPT
45 anterior cranial fossa meningioma 10.4 F2 TP53
46 analbuminemia 10.4 ALB F2 GPT
47 biphasic synovial sarcoma 10.4 CDH1 MUC1
48 acute liver failure 10.4 ALB F2 GPT
49 squamous cell carcinoma of the oropharynx 10.3 CDKN2A TP53
50 spitz nevus 10.3 CDKN2A TP53

Comorbidity relations with Cholecystitis via Phenotypic Disease Network (PDN): (show all 13)


Acute Cystitis Acute Pancreatitis
Cholangitis Cholestasis
Chronic Myocardial Ischemia Deficiency Anemia
Esophagitis Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Ischemic Heart Disease Paralytic Ileus
Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Cholecystitis:



Diseases related to Cholecystitis

Symptoms & Phenotypes for Cholecystitis

MGI Mouse Phenotypes related to Cholecystitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.02 TP53 HP ALB MUC2 CDH1 RASSF1
2 cardiovascular system MP:0005385 10.01 TP53 HP MUC2 CDH1 RASSF1 CDKN2A
3 digestive/alimentary MP:0005381 9.92 ALB MUC2 CDH1 RASSF1 CDKN2A TP53
4 homeostasis/metabolism MP:0005376 9.9 HP ALB MUC2 CCK CDH1 RASSF1
5 endocrine/exocrine gland MP:0005379 9.86 TP53 ALB MUC2 CCK CDH1 RASSF1
6 liver/biliary system MP:0005370 9.5 ALB KRT18 RASSF1 CDKN2A TP53 ABCB4
7 neoplasm MP:0002006 9.23 ALB MUC2 CDH1 RASSF1 CDKN2A TP53

Drugs & Therapeutics for Cholecystitis

Drugs for Cholecystitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 149)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
2
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
3 Nefopam Approved, Investigational Phase 4 13669-70-0
4
Remifentanil Approved Phase 4 132875-61-7 60815
5
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
6
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 5311068 56032 68602
7
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
8
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
9
Metronidazole Approved Phase 4 443-48-1 4173
10
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
11
Ceftriaxone Approved Phase 4,Phase 2 73384-59-5 5479530 5361919
12
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
13
Tigecycline Approved Phase 4 220620-09-7 5282044
14
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
15
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
16
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
17
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 54670067 5785
18 tannic acid Approved, Nutraceutical Phase 4
19 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
20 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2
21 Anti-Infective Agents Phase 4,Phase 3,Phase 2
22 Coagulants Phase 4
23 Hemostatics Phase 4
24 Analgesics Phase 4
25 Analgesics, Non-Narcotic Phase 4
26 Anesthetics Phase 4,Phase 2,Phase 3
27 Anesthetics, Dissociative Phase 4
28 Anesthetics, General Phase 4
29 Anesthetics, Intravenous Phase 4
30 Central Nervous System Depressants Phase 4
31 Excitatory Amino Acid Antagonists Phase 4
32 Excitatory Amino Acids Phase 4
33 Neurotransmitter Agents Phase 4
34 Peripheral Nervous System Agents Phase 4
35 Anesthetics, Local Phase 4
36 Anti-Arrhythmia Agents Phase 4
37 Diuretics, Potassium Sparing Phase 4
38 Sodium Channel Blockers Phase 4
39 Anti-Inflammatory Agents Phase 4
40 Gastrointestinal Agents Phase 4
41 Antioxidants Phase 4
42 Micronutrients Phase 4
43 Protective Agents Phase 4
44 Trace Elements Phase 4
45 Vitamins Phase 4
46 Adrenergic Agents Phase 4
47 Adrenergic Agonists Phase 4
48 Adrenergic alpha-2 Receptor Agonists Phase 4
49 Adrenergic alpha-Agonists Phase 4
50 Analgesics, Opioid Phase 4

Interventional clinical trials:

(show top 50) (show all 111)

# Name Status NCT ID Phase Drugs
1 Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis Unknown status NCT02057679 Phase 4 Amoxicillin clavulanic;Placebo
2 Efficacy and Safety of Floseal for the Haemostasis During Laparoscopic Cholecystectomy in Acute Cholecystitis (GLA) Unknown status NCT01126281 Phase 4
3 Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia Unknown status NCT02493231 Phase 4 Nefopam;Ketamine;Saline
4 Vitamin C Efficacy in Reducing Post Operative Pain Completed NCT01322061 Phase 4 Ascorbic Acid
5 Anesthesia With Propofol, Dexmedetomidine and Lidocaine Infusions for Laparoscopic Cholecystectomy Completed NCT01833819 Phase 4 Dexmedetomidine and lidocaine;Remifentanil
6 DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study Completed NCT01744847 Phase 4
7 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4 etoricoxib 120 mg
8 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Completed NCT00195351 Phase 4 tigecycline;ceftriaxone sodium + metronidazole
9 Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction Completed NCT00280709 Phase 4
10 UDCA for Symptomatic Gallstone Disease Completed NCT00161083 Phase 4 ursodeoxycholic acid
11 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Completed NCT00230971 Phase 4 tigecycline;ceftriaxone plus metronidazole
12 Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Recruiting NCT02812186 Phase 4 Rocuronium
13 Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA Withdrawn NCT02056678 Phase 4 acetaminophen, IV preparation
14 Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Withdrawn NCT00463762 Phase 4 CP-75385-02 Cefoperazone/sulbactam
15 Drainage is Not Necessary Procedure After Laparoscopic Cholecystectomy Due to Severe Acute Cholecystitis Unknown status NCT01625247 Phase 3
16 Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy Unknown status NCT00904865 Phase 2, Phase 3
17 Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Completed NCT00447304 Phase 3 moxifloxacin
18 Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis Completed NCT01015417 Phase 3 Amoxicillin clavulanic acid
19 Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed NCT00229060 Phase 3 doripenem
20 Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed NCT00210938 Phase 3 Doripenem
21 Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Completed NCT00370344 Phase 2, Phase 3
22 Surgery Or Lifestyle Intervention for Type 2 Diabetes (SOLID) Completed NCT01040468 Phase 3
23 A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA Completed NCT01686776 Phase 3
24 Indications for Gallbladder Surgery in Gallstone Disease Completed NCT01190280 Phase 3
25 Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones Completed NCT02592811 Phase 3
26 A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis. Recruiting NCT02212717 Phase 2, Phase 3
27 Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis Recruiting NCT02619149 Phase 3 Piperacillin-tazobactam combination product;Saline solution
28 Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder Unknown status NCT01174069 Phase 1, Phase 2
29 Does it Make Sense to Give Postoperative Antibiotics to Patients With an Uncomplicated Acute Cholecystitis Completed NCT00323648 Phase 2 Whether or not giving postoperatively antibiotics to patients with an uncomplicated acute cholecystitis
30 Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP Completed NCT02098486 Phase 2 Moxifloxacin;ceftriaxone
31 Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study Completed NCT02070627 Phase 1 Indocyanine Green (ICG)
32 Transvaginal Cholecystectomy Using Endoscopic Assistance Withdrawn NCT00815438 Phase 1
33 Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study Unknown status NCT02130245
34 Transient ECG Changes in Patients With Acute Biliary Disease Unknown status NCT01706068
35 Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy Unknown status NCT02224170 Lidocaine;Dexamethasone
36 Role of the Right Portal Pedicle and Rouviere's Sulcus as an Anatomic Landmark in Laparoscopic Cholecystectomy Unknown status NCT02133027
37 Efficacy of Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy on a Virtual Reality Simulator Unknown status NCT01615549
38 Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration Unknown status NCT02461147
39 Functional MRC With Eovist for Acute Cholecystitis Completed NCT02100358
40 Correlation Between Power Doppler and Intraoperative Findings of Chronic and Acute Cholecystitis Completed NCT02156947
41 The Real World of Acute Cholecystitis Completed NCT02796443
42 FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis Completed NCT00590395 18FDG (an FDA-approved radiopharmaceutical)
43 Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis Completed NCT00746850
44 Prospective Trial for Endoscopic Ultrasound Guided Gallbladder Drainage for Acute Cholecystitis in High Risk Patients Completed NCT01146743
45 The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy. Completed NCT01894321
46 Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder? Completed NCT02490293 Cephalosporin;Placebo
47 The Role of Antibiotic Treatment in Patients With Acute Mild Cholecystitis - A Prospective Randomized Controlled Trial Completed NCT00557453 Antibiotic treatment;No antibiotics
48 Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy Completed NCT02394327
49 Early Versus Delayed Cholecystectomy Completed NCT03122054
50 Extent of Surgical Trauma in Open and Laparoscopic Cholecystectomy Completed NCT01077115

Search NIH Clinical Center for Cholecystitis

Cochrane evidence based reviews: cholecystitis

Genetic Tests for Cholecystitis

Genetic tests related to Cholecystitis:

# Genetic test Affiliating Genes
1 Cholecystitis 28 ABCB4

Anatomical Context for Cholecystitis

The Foundational Model of Anatomy Ontology organs/tissues related to Cholecystitis:

18
The Gallbladder

MalaCards organs/tissues related to Cholecystitis:

38
Liver, B Cells, Breast, Bone, Bone Marrow, Colon, Testes

Publications for Cholecystitis

Articles related to Cholecystitis:

(show top 50) (show all 1526)
# Title Authors Year
1
Evaluation of the Safety and Efficacy of Percutaneous Transhepatic Gallbladder Drainage Combined with Laparoscopic Cholecystectomy for Treating Acute Complicated Cholecystitis. ( 29428040 )
2018
2
Percutaneous cholecystostomy: A simple bridge to surgery or an alternative option for the management of acute cholecystitis? ( 29429546 )
2018
3
Meta-analysis of outcomes of endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for the management of acute cholecystitis. ( 29404731 )
2018
4
Validation of the AAST EGS acute cholecystitis grade and comparison with the Tokyo guidelines. ( 29325783 )
2018
5
Xanthogranulomatous cholecystitis shows overlapping histological features with IgG4-related cholecystitis. ( 29023932 )
2018
6
Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. ( 29090868 )
2018
7
Percutaneous cholecystostomy for severe (Tokyo 2013 stage III) acute cholecystitis. ( 29372265 )
2018
8
In response to the article entitled "The Parkland grading scale for cholecystitis" by Madni etA al. In Madni TD, Leshikar DE, Minshall CT, Nakonezny PA, Cornelius CC, Imran JB, Clark AT, Williams BH, Eastman AL, Minei JP, Phelan HA. The Parkland grading scale for cholecystitis. In Am J Surg; 2017 Jun 6. doi.org/10.1016/j.amjsurg.2017.05.017. ( 29397886 )
2018
9
Managing acute cholecystitis among Medicaid insured in New York State: opportunities to optimize care. ( 29435753 )
2018
10
A Hybrid procedure combining endoscopic gallbladder lavage and internal drainage with elective cholecystectomy for acute cholecystitis: a prospective pilot study (The BLADE study). ( 29399891 )
2018
11
Panparietal cholesterolosis: xantho-granulomatous cholecystitis precursor? ( 29307148 )
2018
12
An Immunopathological Evaluation of the Porcine Cholecyst Matrix as a Muscle Repair Graft in a Male Rat Abdominal Wall Defect Model. ( 29334850 )
2018
13
An observational study of the timing of surgery, use of laparoscopy and outcomes for acute cholecystitis in the USA and UK. ( 29313126 )
2018
14
Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis. ( 29266548 )
2018
15
Successful treatment of<i>Providencia rettgeri</i>cholecystitis and neutrophilic cholangitis in a cat. ( 29399368 )
2018
16
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. ( 29090866 )
2018
17
Evaluation of management and surgical outcomes in pregnancies complicated by acute cholecystitis. ( 29369817 )
2018
18
Tokyo Guidelines 2018: updated Tokyo Guidelines for the management of acute cholangitis/acute cholecystitis. ( 29334699 )
2018
19
Laparoscopic cholecystectomy in the treatment of acute cholecystitis: comparison of results between early and late cholecystectomy. ( 28451027 )
2017
20
Transcatheter embolization of a cystic artery pseudoaneurysm in a cirrhotic patient with perforated acute cholecystitis. ( 29379251 )
2017
21
Acute cholecystitis in elderly patients: A case for early cholecystectomy. ( 28939365 )
2017
22
Subspecialty approach for the management of acute cholecystitis: an alternative to acute surgical unit model of care. ( 28512772 )
2017
23
Hyalinizing Cholecystitis and Associated Carcinoma: A Case Report. ( 28372345 )
2017
24
MORTALITY OF URGENCY VERSUS ELECTIVE VIDEOLAPAROSCOPIC CHOLECYSTECTOMY FOR ACUTE CHOLECYSTITIS. ( 28489169 )
2017
25
Acute acalculous cholecystitis in patients with systemic lupus erythematosus: A unique form of disease flare. ( 28355987 )
2017
26
Leptospirosis presenting as acute acalculous cholecystitis. ( 29152269 )
2017
27
Acalculous cholecystitis in a female with cardiac device-related infective endocarditis. ( 28987045 )
2017
28
Acalculous Cholecystitis in Burn Patients: Is There a Role for Percutaneous Cholecystostomy? ( 28576245 )
2017
29
Infiltrative xanthogranulomatous cholecystitis mimicking aggressive gallbladder carcinoma: A diagnostic and therapeutic dilemma. ( 29358875 )
2017
30
Outcomes in Older Patients with Grade III Cholecystitis and Cholecystostomy Tube Placement: A Propensity Score Analysis. ( 28069529 )
2017
31
Hybrid Percutaneous-Endoscopic Treatment for Acute Calculous Cholecystitis in a High-Risk Surgical Patient. ( 28761892 )
2017
32
Risk factors for poor outcomes of children with acute acalculous cholecystitis. ( 28499592 )
2017
33
Diagnosis of emphysematous cholecystitis with bedside ultrasound in a septic elderly female with no source of infection. ( 28367016 )
2017
34
Allopurinol-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Cause of Acalculous Cholecystitis? ( 29057181 )
2017
35
Erratum in: "Erratum to Recurrence of gallstone disease following non-surgical treatment of acute cholecystitis in the elderly population" [Med Clin (Barc). (2017) 149(3)-139]. ( 28756832 )
2017
36
Hepatitis A with Superadded Salmonella paratyphi A Infection Presenting with Exudative Pleural Effusion and Acalculous Cholecystitis. ( 28667735 )
2017
37
Prediction of difficult laparoscopic cholecystectomy for acute cholecystitis. ( 28807199 )
2017
38
Percutaneous cholecystostomy for delayed laparoscopic cholecystectomy in patients with acute cholecystitis: analysis of a single-centre experience and literature review. ( 29358993 )
2017
39
Severe Murine Typhus Presenting with Acalculous Cholecystitis: A Case Report and Literature Review. ( 28473857 )
2017
40
Clinical Cholecystitis in the Absence of the Gallbladder. ( 29340256 )
2017
41
Percutaneous transcystic balloon dilation for common bile duct stone removal in high-surgical-risk patients with acute cholecystitis and co-existing choledocholithiasis. ( 29146469 )
2017
42
Outcomes of Consistent Conservative Management for Acute Cholecystitis Followed by Delayed Cholecystectomy. ( 28906420 )
2017
43
Perforated emphysematous cholecystitis managed by endoscopic transpapillary gallbladder drainage. ( 28516371 )
2017
44
Patient with metastatic breast cancer presenting as acute cholecystitis with one-year survival on hormonotherapy. ( 28905808 )
2017
45
The Effervescent Gallbladder: An Emergency Medicine Bedside Ultrasound Diagnosis of Emphysematous Cholecystitis. ( 29104833 )
2017
46
Perioperative antibiotic prophylaxis in the treatment of acute cholecystitis (PEANUTS II trial): study protocol for a randomized controlled trial. ( 28835268 )
2017
47
Acute cholecystitis in a parastomal hernia causing a small bowel obstruction. ( 29423157 )
2017
48
Haemorrhagic cholecystitis in a newly anticoagulated patient. ( 28404563 )
2017
49
Recurre of gallstone disease following non-surgical treatment of acute cholecystitis in the elderly population. ( 28396133 )
2017
50
Upregulation of CA 19-9 in Complicated Cholecystitis. ( 28424112 )
2017

Variations for Cholecystitis

ClinVar genetic disease variations for Cholecystitis:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 ABCB4 NM_018849.2(ABCB4): c.1328_1329delAGinsCAA (p.Gln443Profs) indel Pathogenic rs387906528 GRCh37 Chromosome 7, 87072662: 87072663
2 ABCB4 NM_018849.2(ABCB4): c.1633C> G (p.Arg545Gly) single nucleotide variant Pathogenic rs397514620 GRCh37 Chromosome 7, 87069081: 87069081
3 ABCB4 NM_018849.2(ABCB4): c.3629C> G (p.Ser1210Ter) single nucleotide variant Pathogenic rs748842753 GRCh37 Chromosome 7, 87032476: 87032476

Expression for Cholecystitis

Search GEO for disease gene expression data for Cholecystitis.

Pathways for Cholecystitis

GO Terms for Cholecystitis

Cellular components related to Cholecystitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 Golgi lumen GO:0005796 8.92 F2 MUC1 MUC2 MUC6

Biological processes related to Cholecystitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 stimulatory C-type lectin receptor signaling pathway GO:0002223 9.58 MUC1 MUC2 MUC6
2 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator GO:0006978 9.37 MUC1 TP53
3 positive regulation of protein oligomerization GO:0032461 9.32 CCK TP53
4 replicative senescence GO:0090399 9.26 CDKN2A TP53
5 maintenance of gastrointestinal epithelium GO:0030277 9.16 MUC2 MUC6
6 Ras protein signal transduction GO:0007265 9.13 CDKN2A RASSF1 TP53
7 O-glycan processing GO:0016266 8.8 MUC1 MUC2 MUC6

Sources for Cholecystitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....